D-1176-2017 Class II Terminated
FDA drug recall D-1176-2017 was initiated by RemedyRepack Inc. on Aug 22, 2017 and is designated Class II. Reason for recall: Crystallization: Product is being recalled due to the manufacturer's recall due to the presence of visible particulate in vials that has been identified as crystalline ketorolac calcium salt. The recall status is terminated (terminated Jan 3, 2018). Affected quantity: 40 vials.
Recall details
- Product Type
- Drugs
- Report Date
- Oct 4, 2017
- Initiation Date
- Aug 22, 2017
- Termination Date
- Jan 3, 2018
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 40 vials
Product description
Ketorolac Trom 30 mg/mL Injection, packaged in a) 1 mL vials, NDC 61786-0741-01 (Orig: 00548-9021-00), Ref: 33631 and b) 10 x 1 mL vials per tray, NDC 61786-0741-08 (Orig: 00548-9021-00), Ref: 33632, Rx only, Packaged by: RemedyRepack Inc, Indiana, PA 15704; Mfg by: Amphastar, Rancho Cucamonga, CA 91730.
Reason for recall
Crystallization: Product is being recalled due to the manufacturer's recall due to the presence of visible particulate in vials that has been identified as crystalline ketorolac calcium salt.
Distribution pattern
Product was distributed to one consignee in Louisiana.
Code information
Lot #: a) B0158730-060816 (Mfg: XI002A6), Exp: 12/2017 ; and b) B0160669-061516 (Mfg: XI003A6), Exp 12/2017
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-1176-2017
- openFDA file date
- Nov 16, 2026
- Loaded by RegDataLab
- Nov 17, 2026